secondaryEndpoint

P67716
predicate

Indicates that something serves as an additional, non-primary endpoint or target associated with a main endpoint in a relationship or process.

All labels observed (3)

Label Occurrences
secondaryEndpoint canonical 16
secondaryTerminus 8
secondaryRouteTerminus 1

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: secondaryEndpoint
Generated description
Indicates that something serves as an additional, non-primary endpoint or target associated with a main endpoint in a relationship or process.

Sample triples (25)

Subject Object
ENGAGE (Study 301) change from baseline in Mini-Mental State Examination (MMSE)
ENGAGE (Study 301) change from baseline in Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog)
ENGAGE (Study 301) change from baseline in Alzheimer’s Disease Cooperative Study–Activities of Daily Living (ADCS-ADL)
ENGAGE (Study 301) amyloid PET imaging measures
ENGAGE (Study 301) CSF biomarker measures
Amtrak Empire Builder Portland Union Station via predicate surface "secondaryRouteTerminus"
Melbourne suburban rail network Southern Cross railway station via predicate surface "secondaryTerminus"
Transilien Line J Mantes-la-Jolie via predicate surface "secondaryTerminus"
Transilien Line J Gisors via predicate surface "secondaryTerminus"
Transilien Line J Ermont–Eaubonne via predicate surface "secondaryTerminus" NERFINISHED
Transilien Line J Pontoise via predicate surface "secondaryTerminus"
Transilien Line J Boissy-l’Aillerie via predicate surface "secondaryTerminus"
Transilien Line J Vernon via predicate surface "secondaryTerminus"
surface form: Vernon (for some services historically or partially)
CLEOPATRA trial objective response rate
CLEOPATRA trial duration of response
CLEOPATRA trial safety
APHINITY trial overall survival
APHINITY trial cardiac safety
Rocky Mountain Rocket Colorado Springs, Colorado via predicate surface "secondaryTerminus" NERFINISHED
CLinical Evaluation Of Pertuzumab And TRAstuzumab
surface form: CLEOPATRA trial
objective response rate
CLinical Evaluation Of Pertuzumab And TRAstuzumab
surface form: CLEOPATRA trial
duration of response
CLinical Evaluation Of Pertuzumab And TRAstuzumab
surface form: CLEOPATRA trial
safety
APHINITY overall survival
APHINITY distant recurrence-free interval
APHINITY cardiac safety